摘要
胃癌的基因治疗作为一种新的治疗手段 ,近年倍受重视 ,在动物实验中取得了可喜的成果。胃癌发病的分子基础是设计基因治疗靶点的依据。胃癌基因治疗的研究主要集中在以下方面 :抑癌基因基因治疗、“自杀”基因基因治疗、反义基因治疗、核酶基因转染治疗、基因免疫治疗等。本文就这些方面的进展作一概述。
出处
《国外医学（临床生物化学与检验学分册）》
2003年第2期93-94,96,共3页
Foreign Medical Sciences(section of Clinical Biochemistry and Laboratory Medicine
同被引文献32
-
1Steele RJC ,Thompson AM, Hall P, et al. The p53 tumour suppressor gene[J].Br J Surg, 1998,85(3) : 1460-1467
-
2Ohash| M,Kanai F, Ueno H,et al. Adenovirus mediated p53 tumor suppressor gene therapy for human gastric cancer ceils in vitoro and in vivo[J].Gut,1999,44(3):366-371
-
3Lowe S,Ruley H .p53-dependent apoptosis modulstes the cytotoxicity of anticancer agents [ J ]. Cell, 1993,362 : 847
-
4Kitadai Y ,Yamazaki H, Yasui W, et al. GC factor respresses transcription of several growth factor/receptor genes and causes growth inhibition of human gastric carcinoma cell lines [J]. Gell Growth Differ, 1993,4(4) : 291-296
-
5Sakakura C,Hagiwara A,Tsujimo H,et al.The anti-proliferative ative effect to proliferating cell nuclear antigen-specific antisense oligonucleotides on human gastric cancer cell lines[J].Surg Today, 1995,25 (2) : 184-186
-
6Chen JP,Lin C,Xu CP,et al.Molecular therapy with recombinant antisense c-myc adenovirus for human gastric carcinoma cells in vitro and in vivo [ J ]. J Gastroenterol Hepatol, 2001,16 ( 1 ) : 22-28
-
7Matsubara H,Tagawa M, Gunji Y,Takenaga K,Sugaya M, Urashima T, Koide Y, Suzuki T, Asano T, Ochiai T, IsonoK, Kageyama H, Nakamura Y ,Sakiyama S. Study of irradiation effects on cytokine secretion from retrovirally transduced tumor cells: a model for tumor vaccination[J].Anticaner Res,1996,16(3): 645-650
-
8Yoshida K, Kswami H, Yamaguchi Y, Kuniyasu H, Nishiyama M, Hirai T,Yamagihara K,Tahara E,Toge T. Retrovirally transmitted gene therapy for gastric carcinoma using herpes simplex virus thymidine gene [ J ]. Cancer, 1995 , 75 (6 Sup-pl ) : 1467-1471
-
9Tanaka T, Kanai F, Lan KH, et al. Adenovirus-mesdiated gane therapy of gastiric carcinoma using cancer-specific gene expression in vivo[J].Biochem Biophy Res Commun,1997,231(3) : 775-779
-
10Ohashi M, Kanai F, Tanaka T; et al. Invivo adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing pancreatic cancer [ J ]. Jpn J Cancer Res, 1998,89 (4) : 457-462
二级引证文献3
-
1钟选芳,许岸高.大肠癌基因治疗的现状[J].实用医学杂志,2005,21(8):865-867. 被引量：1
-
2荣微.IL-2抗肿瘤机制及指导临床的研究述评[J].辽宁中医学院学报,2006,8(1):99-100. 被引量：7
-
3陈蓉,常晋霞,李雪璐,彭丽娟,朱红.粒细胞-巨噬细胞集落刺激因子转染对白血病细胞K562形态及增殖的影响[J].山东医药,2017,57(31):5-8.
-
1范宝珍,毛宏胜,苏剑.胃肿瘤基因治疗研究[J].世界核心医学期刊文摘（眼科学分册）,2003(4):735-737.
-
2葛洪芳,王秀芬（综述）.胃癌基因治疗研究进展[J].国际肿瘤学杂志,2007,34(7):509-511.
-
3陈坛輈,黄智铭,周丽萍.肝细胞癌的基因免疫治疗[J].温州医学院学报,2005,35(4):342-343.
-
4杨海平,张才全.胃癌基因治疗的研究进展[J].现代肿瘤医学,2008,16(6):1058-1061. 被引量：11
-
5朱友群,万美珍,曹幼甫,佘正尧.胃癌基因水平研究进展[J].现代中西医结合杂志,2001,10(18):1726-1729. 被引量：1
-
6张延龄.从胃癌预后因素来考虑综合治疗方案[J].中国胃肠外科杂志,1998,1(1):57-58. 被引量：2
-
7陆芬英,张尤历.胃癌基因治疗研究进展[J].医学综述,2007,13(3):191-193. 被引量：2
-
8彭瑶,杨公利,钟慕晓,张亚历.基于间充质干细胞的胃癌基因治疗研究[J].胃肠病学和肝病学杂志,2015,24(2):217-219. 被引量：2
-
9余文林,黄宗海.胃癌基因治疗研究进展[J].世界华人消化杂志,1999,7(10):887-889. 被引量：5
-
10毕建耀,姜华静.hTERT表达与胃癌临床特征的相关性研究[J].中国实用乡村医生杂志,2013(12):47-49.
